Reaggregate thymus cultures.

MRC Center for Immune Regulation, University of Birmingham.
Journal of Visualized Experiments 02/2008; DOI: 10.3791/905
Source: PubMed

ABSTRACT Stromal cells within lymphoid tissues are organized into three-dimensional structures that provide a scaffold that is thought to control the migration and development of haemopoeitic cells. Importantly, the maintenance of this three-dimensional organization appears to be critical for normal stromal cell function, with two-dimensional monolayer cultures often being shown to be capable of supporting only individual fragments of lymphoid tissue function. In the thymus, complex networks of cortical and medullary epithelial cells act as a framework that controls the recruitment, proliferation, differentiation and survival of lymphoid progenitors as they undergo the multi-stage process of intrathymic T-cell development. Understanding the functional role of individual stromal compartments in the thymus is essential in determining how the thymus imposes self/non-self discrimination. Here we describe a technique in which we exploit the plasticity of fetal tissues to re-associate into intact three-dimensional structures in vitro, following their enzymatic disaggregation. The dissociation of fetal thymus lobes into heterogeneous cellular mixtures, followed by their separation into individual cellular components, is then combined with the in vitro re-association of these desired cell types into three-dimensional reaggregate structures at defined ratios, thereby providing an opportunity to investigate particular aspects of T-cell development under defined cellular conditions [corrected].

  • [Show abstract] [Hide abstract]
    ABSTRACT: Fetal thymus organ culture (FTOC) is a unique and powerful culture system that allows intrathymic T-lymphocyte development in vitro. T-cell development in FTOC well represents fetal thymocyte development in vivo. Here we describe the basic method for FTOC as well as several related techniques, including reconstitution of thymus lobes with T-lymphoid progenitor cells, high-oxygen submersion culture, reaggregation thymus organ culture, retrovirus-mediated gene transfer to developing thymocytes in FTOC, and coculture of progenitor cells with OP9-DL1 cells.
    Methods in molecular biology (Clifton, N.J.) 01/2013; 946:85-102. DOI:10.1007/978-1-62703-128-8_6 · 1.29 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: In order to investigate the role of thymic epithelial cell (TEC) subsets during T-cell development, we established a new transgenic system, enabling inducible cell-specific ablation as well as marking the TEC subsets using bicistronic bacterial nitroreductase and EGFP genes. Two different lengths of the TSCOT promoter in transgenic mice, named 3.1T-NE and 9.1T-NE, drive EGFP expression into TECs. In adult life, EGFP expression was located in the medulla with a smaller 3.1 kb TSCOT promoter, while it was maintained in the cortex with a 9.1 kb promoter, suggesting putative TEC specific as well as compartment specific cis elements within two promoters. Nitroreductase induced cell death was specific without bystander killing upon the treatment of prodrugs such as nitrofurantoin and metronidazol. The degree of cell death was dependent on the dose of the prodrug in the cell and the fetal thymic organ cultures (FTOCs). Fetal thymic stromal populations were analyzed based on the expression levels of EpCAM, MHCII, CDR1 and/or UEA-1. EGFP expression patterns varied among subsets indicating the differential TSCOT promoter activity in each TEC subset. Prodrug treatment in FTOCs reduced the numbers of total and subsets of thymocytes. A CD4(+)CD8(+) double positive cell population was highly susceptible in both transgenic lines. Surprisingly, there was a distinct reduction in γδ T cell population only in the 9.1T-NE thymus, indicating that they require a NTREGFP expressing TEC population. Therefore, these results support a division of labor within TEC subsets for the αβ and γδ lineage specification.
    Moleculer Cells 11/2012; 34(5):481-93. DOI:10.1007/s10059-012-0246-4 · 14.46 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Tissue engineering is making great strides to repair disease and damage in a wide range of tissues, many of which are high profile and well documented. However, the thymus and secondary lymphoid organs are tissues which have not received significant attention from the research community but are nonetheless important targets for tissue engineering based therapies. These organs are fundamental in developing and maintaining the mammalian immune system and create environments for antigen screening and pathogen removal. This review discusses the function of these organs with reference to tissue development, tissue resident progenitor cells and disease. Subsequently strategies utilised for tissue engineering and regeneration are discussed in conjunction with methods to replicate their function and alternative methods to generate progenitor cells. Introduction Tissue engineering is a multidisciplinary research field which aims to reproduce, repair or augment tissue function of whole or partial organs in individuals suffering disease or trauma. The field has roots in clinical medicine and employs the principles of engineering and materials chemistry with cell biology. This involves the selective use of cells, scaffold biomaterials, growth factors and mechanical stimulation in various combinations to recapitulate an organ in vitro or in vivo. It was first mentioned as a distinct area of research in the 1980's, before coming to prominence through Langer and Vacanti's seminal 1993 article Tissue Engineering (Skalak and Fox 1988; Langer and Vacanti 1993). Since this point thousands of research articles have been published on engineering or repairing practically every organ of the human body, with particular focus on musculoskeletal tissues (2201 publications in 2012), the heart (422) and skin (314). Two groups however, have received comparatively little attention; these are the primary and secondary lymphoid organs (SLO) (less than 10 specific articles in 2012). The primary lymphoid organs are composed of the bone marrow and the thymus, with the thymus being the major site of T cell generation, whilst the SLO comprise lymph nodes and lymphoid follicles in organs such as the spleen, tonsils and adenoids. As a group these organs generate and maintain the mammalian immune system and are fundamental to survival. Despite the compa-rative lack of effort advances have been made in attempting to regenerate these organs or recapitulate their functions and these will be discussed.
    05/2013; 1(5):12-28. DOI:10.14304/SURYA.JPR.V1N5.3

Full-text (2 Sources)

Available from
Sep 2, 2014